Position in PCRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,774,335
-$977,128 QoQ
Shares Held
167,006
-9.0% QoQ
Ownership
0.424%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 81.57251835263403.ToString("F0")%
None 18.427481647365962.ToString("F0")%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $745,649,307 across 34 Drug Manufacturers - Specialty & Generic names. PCRX ranks #14 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
20,014,966 | $270,402,187 | |
| 2 | ZTS |
Zoetis Inc.
|
1,610,634 | $190,393,043 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
512,033 | $67,455,225 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
91,225 | $54,094,599 | |
| 5 | ALKS |
Alkermes plc.
|
741,141 | $26,206,745 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,865,201 | $23,184,446 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
270,262 | $20,783,147 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
269,945 | $20,475,327 |
All Filings in PCRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,774,335 | 167,006 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,751,463 | 183,596 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,236,927 | 203,218 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,809,540 | 326,759 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,841,903 | 355,811 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,109,077 | 324,261 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,951,443 | 129,664 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,377,449 | 187,957 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,019,670 | 206,012 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,241,581 | 214,629 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,938,097 | 226,144 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,861,306 | 246,102 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,568,402 | 258,966 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $9,923,117 | 257,009 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $16,448,262 | 309,236 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,163,015 | 311,544 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $19,620,879 | 257,087 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $15,442,930 | 256,655 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,684,304 | 297,934 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,592,303 | 339,359 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $24,125,537 | 344,208 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $16,128,913 | 269,534 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $14,406,855 | 239,635 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $12,290,886 | 234,246 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,220,316 | 215,339 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||